Target intelligence / Profile preview

Elongation factor Tu–aminoacyl-tRNA complex (EF-Tu:aa-tRNA complex)

Target
EF-Tu:aa-tRNA complex
Molecular classification
Enzyme (GTPase), Protein–nucleic acid complex, Translation factor (elongation factor)
01

Overview

The elongation factor Tu–aminoacyl-tRNA complex is a central protein–nucleic acid assembly in bacterial translation elongation. EF-Tu is a highly conserved bacterial GTPase that binds aminoacyl-tRNA (aa-tRNA) in its GTP-bound form, forming a ternary complex (EF-Tu–GTP–aa-tRNA) that delivers the correct aa-tRNA to the ribosomal A-site according to the mRNA codon sequence. Upon correct codon–anticodon pairing, EF-Tu hydrolyzes GTP, undergoes a conformational change, and releases the tRNA into the ribosome for peptide bond formation, before being recycled in a GTP-dependent manner with the help of EF-Ts. EF-Tu is an essential and ancient translation factor, and its complex with aa-tRNA is a validated antibacterial drug target, with several natural product antibiotics inhibiting this pathway by locking EF-Tu to the tRNA and impairing protein synthesis. Because of its essential role in bacterial viability and highly conserved structure, but significant divergence from eukaryotic homologs, EF-Tu is considered to be an attractive, though not entirely risk-free, therapeutic target for new antibacterial agents.

Other names
Elongation factor Tu–tRNA complexEF-Tu ternary complexEF-Tu–GTP–aminoacyl-tRNA complex
02

Mechanism of action

Inhibition of EF-Tu GTPase activity; Stabilization of EF-Tu:tRNA complex, preventing release of aminoacyl-tRNA; Blocking binding of EF-Tu to the ribosome; Preventing recycling of EF-Tu (by inhibiting EF-Ts-mediated GDP-GTP exchange)

03

Biological functions

Protein synthesis (translation elongation)Fidelity of mRNA decodingAminoacyl-tRNA delivery to the ribosome
04

Disease associations

Infection (antibacterial target)Other (potential antimicrobial resistance involvement)
05

Safety considerations

Target essential for protein synthesis in bacteria; drugs may potentially affect mitochondrial translation in host cellsBacterial resistance mechanisms can emerge
06

Interacting drugs

Kirromycin

4 more in the full profile.

07

Biomarkers

Null (not a clinically established biomarker)

Beyond the preview

Go deeper on Elongation factor Tu–aminoacyl-tRNA complex (EF-Tu:aa-tRNA complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongation factor Tu–aminoacyl-tRNA complex (EF-Tu:aa-tRNA complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call